Wall Street analysts expect Equifax (EFX) to post quarterly earnings of $1.92 per share in its upcoming report, which indicates a year-over-year increase of 5.5%. Revenues are expected to be $1.51 ...

EFX is set to report Q2 results on July 22, with EPS and revenues expected to rise on solid USIS, international and Workforce ...

The market expects Equifax (EFX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is ...

The FTC alleges that the marketers of Xenadrine EFX falsely advertised that the endorsers in their advertisements lost weight solely through use of Xenadrine. They also failed to disclose that the ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Efx Fragments is available now at an introductory price of $99, though if you already own other Arturia products there's probably a steep discount waiting for you.

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the breakthrough Phase 2b SYMMETRY data.

Investors in Equifax Inc (Symbol: EFX) saw new options begin trading today, for the April 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

A good thing about Akero is that it has already provided proof of concept in being able to use its Fc-FGF21 fusion protein drug known as efruxifermin [EFX] to treat patients with NASH fibrosis ...